Annual Reports
AstraZeneca (@AstraZeneca) / X
AstraZeneca | Business | The Guardian
AstraZeneca wins EU backing for heart drug, but suffers lung cancer setback | Reuters
AstraZeneca launches Evinova to bring AI to clinical trials | MobiHealthNews
Transforming AstraZeneca's R&D productivity
AstraZeneca US
AstraZeneca - Research-Based BioPharmaceutical Company
How the Oxford-AstraZeneca Covid-19 Vaccine Works - The New York Times
FDA pulls authorization for AstraZeneca's Covid antibody drug Evusheld
No plans for UK to order more supplies of AstraZeneca Covid vaccine | Coronavirus | The Guardian
Annual Reports
AstraZeneca unveils successes in treatment of lung cancer
Coronavirus (COVID-19) information & research hub | AstraZeneca
EXCLUSIVE AstraZeneca exploring options for COVID-19 vaccine business - executive | Reuters
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework | Nature Reviews Drug Discovery
AstraZeneca, U.S. agree 500,000 more supplies of COVID-19 antibody cocktail | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CZ52QGK6OVNLFOT6X2BUOAEG5M.jpg "U.S. FDA pulls authorization for AstraZeneca's COVID-19 treatment Evusheld | Reuters")
U.S. FDA pulls authorization for AstraZeneca's COVID-19 treatment Evusheld | Reuters
AstraZeneca | Business | The Guardian
Externally Sponsored Scientific Research - AstraZeneca
Annual Reports
ADR programme
Ethics and transparency - Our Company - AstraZeneca
AstraZeneca - Research-Based BioPharmaceutical Company
About Our Company - AstraZeneca
